Basic Information
Basic information for LINC00917-210-29aa
Peptide Name LINC00917-210-29aa
Genome Position chr16:86338750-86338790,86349615-86349660[-]
Species Human
Peptide Sequence MRWSQPRGEPEEGITGLESGGAWLPRGGR
Peptide Length 29
Unique No (LINC00917-202-29aa,LINC00917-208-29aa,LINC00917-209-29aa,LINC00917-215-29aa,LINC00917-216-29aa)
Grand Average of Hydropathicity -1.0828
Relative Molecular Mass 3671.94
Experimental Evidences no
lncRNA ID/Name ENSG00000168367;LINC00917
Transcript ID/Name ENST00000655731;LINC00917-210
Transcript Length 1578
Coding Ability 0.5475
DNA Sequence Corresponding to Peptide ATGAGATGGAGCCAGCCACGTGGTGAGCCAGAAGAGGGCATCACAGGGCTTGAGTCTGGGGGAGCCTGGCTGCCCAGAGGTGGCAGA
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :